Hp eradication decreased the expression level of PG II in patients of Hp negative with gastric intestinal metaplasia: a retrospective cross-sectional study

Hp eradication decreased the expression level of PG II in patients of Hp negative with gastric intestinal metaplasia: a retrospective cross-sectional study

Abstract Aims This study aims to assess the serum levels of pepsinogen (PG)I, PG II, and gastrin (G17) in patients with gastric intestinal metaplasia (GIM) and evaluate their correlation with demographic characteristics. Methods A total of 247 normal controls (NC) and 240 patients diagnosed with GIM...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yanhong Wang, Xixiang Cao, Baodong Shan, Song Chen, Shengnan Li, Sujuan Fei, Xunlei Pang
Format:	Article
Language:	English
Published:	BMC 2025-01-01
Series:	Journal of Health, Population and Nutrition
Subjects:	Pepsinogen Gastric mucosal intestinal metaplasia Outpatient Helicobacter pylori eradication history
Online Access:	https://doi.org/10.1186/s41043-025-00756-y
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The prevalence of atrophic gastritis of the body of stomach at Krasnoyarsk population over 45 years old
by: V. V. Tsukanov, et al.
Published: (2012-07-01)

Results of long-term follow-up of patients with chronic gastritis after <i>H. pylori</i> eradication
by: T. L. Lapina, et al.
Published: (2015-09-01)

Short-term endoscopic alterations of early gastric cancer after successful eradication of Helicobacter pylori
by: Xiaohan Yan, et al.
Published: (2025-02-01)

Discussion of <i>Helicobacter pylori</i> infection issue in reports of the 19-th United European Gastroenterology Week
by: A. A. Sheptulin, et al.
Published: (2012-09-01)

Helicobacter pylori SlyD stabilizes TPT1 via hnRNPK and enhances OCT1-mediated CDX2 transcriptional activation to drive gastric intestinal metaplasia
by: Shuwen Zheng, et al.
Published: (2025-02-01)

Efficacy and safety of Saccharomyces boulardii as an adjuvant therapy for the eradication of Helicobacter pylori: a meta-analysis
by: Manning Li, et al.
Published: (2025-02-01)

Infection <i>Helicobacter pylori</i> and stomach cancer: state-of-the-art
by: A. A. Sheptulin
Published: (2012-04-01)

Review of the European <i>Helicobacter</i> Study Group Workshop reports (Ljubljana, 2012)
by: A. A. Sheptulin
Published: (2013-07-01)

Clinical Recommendations of Russian Gastroenterological Association and RENDO Endoscopic Society on Diagnosis and Treatment of Gastritis and Duodenitis
by: V. T. Ivashkin, et al.
Published: (2021-12-01)

<i>Helicobacter pylori</i> HP0135 Is a Small Lipoprotein That Has a Role in Outer Membrane Stability
by: Doreen Nguyen, et al.
Published: (2025-01-01)

Management approach to patients with premalignant lesions of the stomach
by: V. V. Tsukanov, et al.
Published: (2013-07-01)

Rebamipide during chronic gastritis: <i>H. pylori</i> eradication therapy and restoration of gastric mucosa barrier function
by: Т. L. Lapina, et al.
Published: (2024-01-01)

Weizmannia coagulans BC99 modulate gut microbiota after Helicobacter pylori eradication: A randomized double-blind placebo-controlled trial
by: Ying Wu, et al.
Published: (2025-02-01)

Association of high organochlorine pesticide serum levels with oxidative stress in intestinal metaplasia and gastric cancer
by: Gholamreza Asadikaram, et al.
Published: (2025-01-01)

Prevalence of Erosive-ulcerative Lesions of the Stomach and Helicobacter Pylori Infection in Patients with Ulcerative Colitis
by: N. A. Ponkratova, et al.
Published: (2019-06-01)

Pathogenetic Treatment of Gastritis as a Basis for the Prevention of Gastric Cancer in the Countries of the Commonwealth of Independent States: Literature Review and the Resolution of a Scientific Symposium Held in Minsk, Republic of Belarus, January, 27, 2018
by: V. T. Ivashkin, et al.
Published: (2018-09-01)

Helicobacter pylori infection diagnostics and choice of eradication treatment: results of inquiry of doctors from different regions of Russian Federation
by: N. N. Dekhnich, et al.
Published: (2018-08-01)

Helicobacter pylori gastritis in Jordanian children: persistence versus resolution
by: Eyad Altamimi, et al.
Published: (2023-11-01)

The role of bismuth drugs in elevation of Helicobacter pylori infection eradication efficacy
by: A. A. Sheptulin
Published: (2018-08-01)

Hp and pH: Implications for the Eradication of Heliobacter pylori
by: Richard H Hunt
Published: (1993-01-01)

Gastric MALT Lymphoma with Giant Ulcer from Untreated H. pylori: Role of Endoscopic Biopsy – A Case Report.
by: Hysni Dede, et al.
Published: (2025-01-01)

The Role of Lactobacillus reuteri DSMZ17648 for Helicobacter pylori eradication therapy (Review of literature and advisory council resolution, February 28, 2018)
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Clinical and Morphological Manifestations of Gastritis and Serum Cytokine Levels in Schoolchildren with Familial History of Gastric Cancer
by: T. V. Polivanova, et al.
Published: (2021-10-01)

Natural products based on Correa's cascade for the treatment of gastric cancer trilogy: Current status and future perspective
by: Wenhao Liao, et al.
Published: (2025-02-01)

Gastric Microbiota Associated with Gastric Precancerous Lesions in <i>Helicobacter pylori</i>-Negative Patients
by: Han-Na Kim, et al.
Published: (2025-01-01)

Endoscopic resection of mucosa and dissection of submucosal layer at early stomach cancer
by: S. V. Kashin, et al.
Published: (2011-03-01)

Impact of Helicobacter pylori infection on neoadjuvant chemotherapy in locally advanced gastric cancer: a retrospective analysis
by: Bin Zhong, et al.
Published: (2025-01-01)

Clinical Practice Guidelines of Russian Gastroenterological Association, Scientific Society for the Clinical Study of Human Microbiome, Russian Society for the Prevention of Non-Communicable Diseases, Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy for <i>H. pylori</i> Diagnostics and Treatment in Adults
by: V. T. Ivashkin, et al.
Published: (2023-05-01)

Prognosis of erosions development at gastric metaplasia of esophageal mucosa in patients with gastroesophageal reflux disease
by: Ye. K. Mastykova, et al.
Published: (2012-11-01)

Prevalence of CagA-positive Helicobacter pylori strain and H. pylori-associated gastritis activity in Tuva schoolchildren of different age groups
by: Tamara V. Polivanova, et al.
Published: (2018-08-01)

Characterization of Helicobacter Pylori Infection in Patients with Gastric Ulcer
by: Marcos Félix Osorio Pagola, et al.
Published: (2009-12-01)

Improvement of Helicobacter pylori eradication efficacy at stomach and duodenum peptic ulcers
by: Natalya O. Schanova, et al.
Published: (2016-08-01)

Diagnostics and treatment of Helicobacter pylori infection in adults: Clinical guidelines of the Russian gastroenterological association
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Modern Approaches to <i>H. pylori</i> Eradication Therapy in Adults (Literature Review and Resolution of Experts Council)
by: V. Т. Ivashkin, et al.
Published: (2023-05-01)

Xantelasma gástrico y Helicobacter pylori. Reporte de un caso y revisión de la literatura
by: Rafael Pila Pérez, et al.
Published: (2013-02-01)

Diagnosing MALT Gastric Lymphoma in Gastroenterologist’s Practice, a Clinical Observation
by: E. Ya. Selezneva, et al.
Published: (2021-10-01)

High-dose dual therapy for Helicobacter pylori eradication inducing less impact on the gut microbiota
by: Jia-Lun Guan, et al.
Published: (2025-01-01)

Growth of HP functions in tubes
by: Richard D. Carmichael, et al.
Published: (1981-01-01)

Rational choice of eradication therapy of <i>Helicobacter pylori</i> infection
by: T. L. Lapina, et al.
Published: (2013-10-01)

A mathematical model for the study of latent tuberculosis under 3HP and 1HP regimens
by: Erick M. D. Moya, et al.
Published: (2024-11-01)